Home / IDUA Knockout Cell Lines

IDUA Knockout Cell Lines

Gene: IDUA

Official Full Name: alpha-L-iduronidaseprovided by HGNC

Gene Summary: This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO04514 IDUA Knockout cell line (HeLa) Human IDUA 1:3~1:6 Negative Online Inquiry
KO04515 IDUA Knockout cell line (HCT 116) Human IDUA 1:2~1:4 Negative Online Inquiry
KO04516 IDUA Knockout cell line (A549) Human IDUA 1:3~1:4 Negative Online Inquiry

Background

IDUA Gene Knockout Cell Lines represent a cutting-edge biological tool designed to facilitate advanced research in the field of genetics and cellular biology. These cell lines are specifically engineered to lack the IDUA (Iduronidase) gene, which is critical for the degradation of glycosaminoglycans (GAGs) such as heparan sulfate and dermatan sulfate. By providing a model system where the IDUA gene is inactivated, researchers can study the effects of its absence on cellular function and metabolism, enriching our understanding of lysosomal storage disorders, particularly Hurler and Scheie syndromes.

The primary function of IDUA Gene Knockout Cell Lines is to serve as a valuable platform for investigating enzyme replacement therapies, gene therapies, and other therapeutic modalities aimed at addressing the pathophysiological consequences of IDUA deficiency. The knockout mechanism elucidates the downstream metabolic alterations and therapeutic targets that could alleviate the disease's symptoms. Researchers can utilize these cell lines to screen potential drug candidates, assess the efficacy of gene editing approaches, and explore novel biochemical pathways involved in GAG metabolism and related disorders.

In the scientific community, the importance of these cell lines extends to their application in both research and clinical settings. They provide an invaluable model for pharmacological studies, enabling scientists to develop and refine treatments that exploit the cellular mechanisms compromised by IDUA gene loss. Furthermore, the use of IDUA knockout models can enhance the understanding of molecular pathways in glycosaminoglycan metabolism, potentially leading to the discovery of biomarkers for early diagnosis or progression of related diseases.

What sets IDUA Gene Knockout Cell Lines apart from other genetic models is their specificity and relevance to lysosomal storage disorders. Many alternative models lack the nuanced biological features that allow for the detailed study of IDUA-related pathologies. These cell lines offer superior reproducibility, consistent performance, and readily accessible background data, which significantly accelerates research progress and enhances reliability in experimental outcomes.

Researchers, clinicians, and biopharmaceutical companies will find IDUA Gene Knockout Cell Lines to be an essential addition to their toolkit, enabling them to pursue groundbreaking therapies and further their understanding of complex genetic diseases. With a commitment to innovation and scientific excellence, our company is dedicated to providing high-quality biological products that empower researchers to make impactful discoveries in genetics and beyond.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.